<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04926935</url>
  </required_header>
  <id_info>
    <org_study_id>09</org_study_id>
    <nct_id>NCT04926935</nct_id>
  </id_info>
  <brief_title>Bloodstram Infections in ICU. Single Centre Observational Study.</brief_title>
  <official_title>Bloodstram Infections in Intensive Care Unit. A Single Centre Bacteriological Analysis Between 2007-2019.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Military Institute of Medicine, Poland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Military Institute of Medicine, Poland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hospital-acquired bloodstream infection (BSI) is serious care problem worldwide associated&#xD;
      with significant morbidity and mortality. However, only few nationwide studies have focused&#xD;
      on the incidence of BSI, and its results were often inconsistent.&#xD;
&#xD;
      The objective of this study was to analyze bloodstream infections in patients hospitalized in&#xD;
      the intensive care unit of the tertiary, university hospital. Special attention was put on&#xD;
      the etiology of the infections, the antimicrobial susceptibility/resistance of the isolated&#xD;
      pathogens, as well as the incidence of central vein catheters infections in the analyzed&#xD;
      population.&#xD;
&#xD;
      Data were collected in the intensive care unit of the Military Institute of Medicine, Warsaw,&#xD;
      Poland, between January, 1, 2007 and December, 31, 2019.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2007</start_date>
  <completion_date type="Actual">December 31, 2019</completion_date>
  <primary_completion_date type="Actual">December 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Results of microbiological analysis.</measure>
    <time_frame>After completion of the microbiological analysis, up to 72 hours.</time_frame>
    <description>Results of the microbiological analysis of the blood samples collected from patients with clinically suspected infections hospitalized in the ICU during the study period.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Isolated pathogens' susceptibility for antimicrobial agents. .</measure>
    <time_frame>After completion of the microbiological analysis, up to 72 hours.</time_frame>
    <description>Results of the microbiological analysis of the blood samples collected from patients with clinically suspected infections hospitalized in the ICU during the study period.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Isolated pathogens' resistance for antimicrobial agents. .</measure>
    <time_frame>After completion of the microbiological analysis, up to 72 hours.</time_frame>
    <description>Results of the microbiological analysis of the blood samples collected from patients with clinically suspected infections hospitalized in the ICU during the study period.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">3502</enrollment>
  <condition>Bloodstream Infection</condition>
  <condition>Antibiotic Resistant Strain</condition>
  <condition>Intensive Care Unit</condition>
  <arm_group>
    <arm_group_label>Patients hospitalized in the ICU during the study period.</arm_group_label>
    <description>Patients hospitalized in the ICU during the study period with clinically suspected infection.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Microbiological analysis of blood samples.</intervention_name>
    <description>Microbiological analysis of blood samples collected from the patients with clinically suspected infection.</description>
    <arm_group_label>Patients hospitalized in the ICU during the study period.</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients hospitalized in the ICU with clinically suspected infection between 2007-2019.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  all patients hospitalized in the ICU with clinically suspected infection.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  none.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dariusz Tomaszewski, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Military Institute of Medicine, Poland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Anesthesiology and Intensive Therapy</name>
      <address>
        <city>Warsaw</city>
        <zip>04-141</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <results_reference>
    <citation>Garrouste-Orgeas M, Timsit JF, Tafflet M, Misset B, Zahar JR, Soufir L, Lazard T, Jamali S, Mourvillier B, Cohen Y, De Lassence A, Azoulay E, Cheval C, Descorps-Declere A, Adrie C, Costa de Beauregard MA, Carlet J; OUTCOMEREA Study Group. Excess risk of death from intensive care unit-acquired nosocomial bloodstream infections: a reappraisal. Clin Infect Dis. 2006 Apr 15;42(8):1118-26. Epub 2006 Mar 14. Erratum in: Clin Infect Dis. 2006 Jun 15;42(12):1818.</citation>
    <PMID>16575729</PMID>
  </results_reference>
  <results_reference>
    <citation>Laupland KB, Lee H, Gregson DB, Manns BJ. Cost of intensive care unit-acquired bloodstream infections. J Hosp Infect. 2006 Jun;63(2):124-32. Epub 2006 Apr 18.</citation>
    <PMID>16621137</PMID>
  </results_reference>
  <results_reference>
    <citation>Wilson J, Elgohari S, Livermore DM, Cookson B, Johnson A, Lamagni T, Chronias A, Sheridan E. Trends among pathogens reported as causing bacteraemia in England, 2004-2008. Clin Microbiol Infect. 2011 Mar;17(3):451-8. doi: 10.1111/j.1469-0691.2010.03262.x.</citation>
    <PMID>20491834</PMID>
  </results_reference>
  <results_reference>
    <citation>Nielsen SL, Pedersen C, Jensen TG, Gradel KO, Kolmos HJ, Lassen AT. Decreasing incidence rates of bacteremia: a 9-year population-based study. J Infect. 2014 Jul;69(1):51-9. doi: 10.1016/j.jinf.2014.01.014. Epub 2014 Feb 25.</citation>
    <PMID>24576825</PMID>
  </results_reference>
  <results_reference>
    <citation>de Kraker ME, Jarlier V, Monen JC, Heuer OE, van de Sande N, Grundmann H. The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System. Clin Microbiol Infect. 2013 Sep;19(9):860-8. doi: 10.1111/1469-0691.12028. Epub 2012 Oct 8.</citation>
    <PMID>23039210</PMID>
  </results_reference>
  <results_reference>
    <citation>Goto M, Al-Hasan MN. Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin Microbiol Infect. 2013 Jun;19(6):501-9. doi: 10.1111/1469-0691.12195. Epub 2013 Mar 8. Review.</citation>
    <PMID>23473333</PMID>
  </results_reference>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 4, 2021</study_first_submitted>
  <study_first_submitted_qc>June 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 15, 2021</study_first_posted>
  <last_update_submitted>June 8, 2021</last_update_submitted>
  <last_update_submitted_qc>June 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Military Institute of Medicine, Poland</investigator_affiliation>
    <investigator_full_name>Dariusz Tomaszewski</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Sepsis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

